Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Apr;35(4):830–835. doi: 10.1128/jcm.35.4.830-835.1997

PCR detection of Pneumocystis carinii in bronchoalveolar lavage specimens: analysis of sensitivity and specificity.

J A Ribes 1, A H Limper 1, M J Espy 1, T F Smith 1
PMCID: PMC229684  PMID: 9157136

Abstract

Although PCR detection of Pneumocystis carinii DNA has been described, little is known about the sensitivity or specificity of the assay in routine laboratory practice. We had the unique opportunity to use a bronchoalveolar lavage (BAL) specimen bank with samples for which the direct examination results for P. carinii were known. DNA purified from 129 selected specimens was amplified by using the primers described previously (A. E. Wakefield, F. J. Pixley, S. Banerji, K. Sinclair, R. F. Miller, E. R. Moton, and J. M. Hopkin, Mol. Biochem. Parasitol. 43:69-76, 1990). Of the 129 specimens, 37 were positive for P. carinii by direct examination. All 37 specimens were positive for P. carinii by PCR, yielding a 100% sensitivity and 100% negative predictive value for the assay. An additional 23 specimens were repeatedly positive for P. carinii by PCR but were not positive by direct examination. Review of the patient charts for these specimens with discordant results demonstrated that five of the patients were actually positive for P. carinii, as determined by either biopsy or examination of repeat or prior BAL specimens. A response to empiric therapy for P. carinii pneumonia was seen in an additional two patients. Of the remaining specimens, 8 produced no significant isolates other than P. carinii, while 12 contained culture-confirmed significant respiratory pathogens in addition to P. carinii (two fungal, nine bacterial, and one viral pathogen). Cytomegalovirus, which was of unknown significance, was isolated from 16 additional specimens. Overall, the specificity of the PCR assay was 79.3% compared to the results of direct examination. We hypothesized that the apparently poor specificity of the PCR assay was due to the increased sensitivity of the assay compared to that of direct examination. The sensitivity of the PCR assay was therefore assessed with BAL specimens containing P. carinii cysts. Serial dilutions of this preparation were evaluated by direct examination and PCR. PCR was found to be 100-fold more sensitive than direct examination, which detected one to two cysts per amplification. No false-positive results were detected in controls containing no DNA or by using target DNA from various fungal, viral, or bacterial respiratory pathogens. We conclude that PCR detection of P. carinii in BAL specimens is very sensitive and should be considered for patients whose specimens do not yield a diagnosis. The increased sensitivity of the PCR assay may help to identify those patients with low-titer infections who might benefit from directed antibiotic therapy for P. carinii and would otherwise be missed by direct examination alone.

Full Text

The Full Text of this article is available as a PDF (1.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armengol C. E. A historical review of Pneumocystis carinii. JAMA. 1995 Mar 1;273(9):747, 750-1. doi: 10.1001/jama.273.9.747. [DOI] [PubMed] [Google Scholar]
  2. Atzori C., Lu J. J., Jiang B., Bartlett M. S., Orlando G., Queener S. F., Smith J. W., Cargnel A., Lee C. H. Diagnosis of Pneumocystis carinii pneumonia in AIDS patients by using polymerase chain reactions on serum specimens. J Infect Dis. 1995 Dec;172(6):1623–1626. doi: 10.1093/infdis/172.6.1623. [DOI] [PubMed] [Google Scholar]
  3. Baselski V. S., Robison M. K., Pifer L. W., Woods D. R. Rapid detection of Pneumocystis carinii in bronchoalveolar lavage samples by using Cellufluor staining. J Clin Microbiol. 1990 Feb;28(2):393–394. doi: 10.1128/jcm.28.2.393-394.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baughman R. P. Use of bronchoscopy in the diagnosis of infection in the immunocompromised host. Thorax. 1994 Jan;49(1):3–7. doi: 10.1136/thx.49.1.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Broaddus C., Dake M. D., Stulbarg M. S., Blumenfeld W., Hadley W. K., Golden J. A., Hopewell P. C. Bronchoalveolar lavage and transbronchial biopsy for the diagnosis of pulmonary infections in the acquired immunodeficiency syndrome. Ann Intern Med. 1985 Jun;102(6):747–752. doi: 10.7326/0003-4819-102-6-747. [DOI] [PubMed] [Google Scholar]
  6. Chouaid C., Roux P., Lavard I., Poirot J. L., Housset B. Use of the polymerase chain reaction technique on induced-sputum samples for the diagnosis of Pneumocystis carinii pneumonia in HIV-infected patients. A clinical and cost-analysis study. Am J Clin Pathol. 1995 Jul;104(1):72–75. doi: 10.1093/ajcp/104.1.72. [DOI] [PubMed] [Google Scholar]
  7. Chusid M. J., Heyrman K. A. An outbreak of Pneumocystis carinii pneumonia at a pediatric hospital. Pediatrics. 1978 Dec;62(6):1031–1035. [PubMed] [Google Scholar]
  8. Contini G., Romani R., Vullo V., Delia S., Sorice F. Does laboratory recovery of Pneumocystis carinii always mean clinically significant disease? AIDS. 1992 Dec;6(12):1558–1559. doi: 10.1097/00002030-199212000-00032. [DOI] [PubMed] [Google Scholar]
  9. DEAMER W. C., ZOLLINGER H. U. Interstitial plasma cell pneumonia of premature and young infants. Pediatrics. 1953 Jul;12(1):11–22. [PubMed] [Google Scholar]
  10. Edman J. C., Kovacs J. A., Masur H., Santi D. V., Elwood H. J., Sogin M. L. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature. 1988 Aug 11;334(6182):519–522. doi: 10.1038/334519a0. [DOI] [PubMed] [Google Scholar]
  11. Espy M. J., Patel R., Paya C. V., Smith T. F. Comparison of three methods for extraction of viral nucleic acids from blood cultures. J Clin Microbiol. 1995 Jan;33(1):41–44. doi: 10.1128/jcm.33.1.41-44.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Esterly J. A., Warner N. E. Pneumocystis carinii pneumonia. Twelve cases in patients with neoplastic lymphoreticular disease. Arch Pathol. 1965 Nov;80(5):433–441. [PubMed] [Google Scholar]
  13. Frenkel J. K., Good J. T., Shultz J. A. Latent Pneumocystis infection of rats, relapse, and chemotherapy. Lab Invest. 1966 Oct;15(10):1559–1577. [PubMed] [Google Scholar]
  14. GAJDUSEK D. C. Pneumocystis carinii; etiologic agent of interstitial plasma cell pneumonia of premature and young infants. Pediatrics. 1957 Apr;19(4 Pt 1):543–565. [PubMed] [Google Scholar]
  15. Gill V. J., Evans G., Stock F., Parrillo J. E., Masur H., Kovacs J. A. Detection of Pneumocystis carinii by fluorescent-antibody stain using a combination of three monoclonal antibodies. J Clin Microbiol. 1987 Oct;25(10):1837–1840. doi: 10.1128/jcm.25.10.1837-1840.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Golden J. A., Hollander H., Stulbarg M. S., Gamsu G. Bronchoalveolar lavage as the exclusive diagnostic modality for Pneumocystis carinii pneumonia. A prospective study among patients with acquired immunodeficiency syndrome. Chest. 1986 Jul;90(1):18–22. doi: 10.1378/chest.90.1.18. [DOI] [PubMed] [Google Scholar]
  17. Griffiths M. H., Kocjan G., Miller R. F., Godfrey-Faussett P. Diagnosis of pulmonary disease in human immunodeficiency virus infection: role of transbronchial biopsy and bronchoalveolar lavage. Thorax. 1989 Jul;44(7):554–558. doi: 10.1136/thx.44.7.554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hughes W. T., McNabb P. C., Makres T. D., Feldman S. Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis. Antimicrob Agents Chemother. 1974 Mar;5(3):289–293. doi: 10.1128/aac.5.3.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hughes W. T. Natural mode of acquisition for de novo infection with Pneumocystis carinii. J Infect Dis. 1982 Jun;145(6):842–848. doi: 10.1093/infdis/145.6.842. [DOI] [PubMed] [Google Scholar]
  20. Jacobs J. L., Libby D. M., Winters R. A., Gelmont D. M., Fried E. D., Hartman B. J., Laurence J. A cluster of Pneumocystis carinii pneumonia in adults without predisposing illnesses. N Engl J Med. 1991 Jan 24;324(4):246–250. doi: 10.1056/NEJM199101243240407. [DOI] [PubMed] [Google Scholar]
  21. Jules-Elysee K. M., Stover D. E., Zaman M. B., Bernard E. M., White D. A. Aerosolized pentamidine: effect on diagnosis and presentation of Pneumocystis carinii pneumonia. Ann Intern Med. 1990 May 15;112(10):750–757. doi: 10.7326/0003-4819-112-10-750. [DOI] [PubMed] [Google Scholar]
  22. Kim Y. K., Parulekar S., Yu P. K., Pisani R. J., Smith T. F., Anhalt J. P. Evaluation of calcofluor white stain for detection of Pneumocystis carinii. Diagn Microbiol Infect Dis. 1990 Jul-Aug;13(4):307–310. doi: 10.1016/0732-8893(90)90022-n. [DOI] [PubMed] [Google Scholar]
  23. Kovacs J. A., Ng V. L., Masur H., Leoung G., Hadley W. K., Evans G., Lane H. C., Ognibene F. P., Shelhamer J., Parrillo J. E. Diagnosis of Pneumocystis carinii pneumonia: improved detection in sputum with use of monoclonal antibodies. N Engl J Med. 1988 Mar 10;318(10):589–593. doi: 10.1056/NEJM198803103181001. [DOI] [PubMed] [Google Scholar]
  24. Leigh T. R., Gazzard B. G., Rowbottom A., Collins J. V. Quantitative and qualitative comparison of DNA amplification by PCR with immunofluorescence staining for diagnosis of Pneumocystis carinii pneumonia. J Clin Pathol. 1993 Feb;46(2):140–144. doi: 10.1136/jcp.46.2.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Leigh T. R., Wakefield A. E., Peters S. E., Hopkin J. M., Collins J. V. Comparison of DNA amplification and immunofluorescence for detecting Pneumocystis carinii in patients receiving immunosuppressive therapy. Transplantation. 1992 Sep;54(3):468–470. doi: 10.1097/00007890-199209000-00016. [DOI] [PubMed] [Google Scholar]
  26. Limper A. H., Offord K. P., Smith T. F., Martin W. J., 2nd Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis. 1989 Nov;140(5):1204–1209. doi: 10.1164/ajrccm/140.5.1204. [DOI] [PubMed] [Google Scholar]
  27. Limper A. H., Specks U., Brutinel W. M., Martin W. J., 2nd, Rohrbach M. S. Interlobar variation in the recovery of bronchoalveolar lavage fluid, cell populations, and angiotensin-converting enzyme in normal volunteers. J Lab Clin Med. 1993 Jun;121(6):785–791. [PubMed] [Google Scholar]
  28. Lipschik G. Y., Gill V. J., Lundgren J. D., Andrawis V. A., Nelson N. A., Nielsen J. O., Ognibene F. P., Kovacs J. A. Improved diagnosis of Pneumocystis carinii infection by polymerase chain reaction on induced sputum and blood. Lancet. 1992 Jul 25;340(8813):203–206. doi: 10.1016/0140-6736(92)90469-j. [DOI] [PubMed] [Google Scholar]
  29. Masur H., Gill V. J., Ognibene F. P., Shelhamer J., Godwin C., Kovacs J. A. Diagnosis of Pneumocystis pneumonia by induced sputum technique in patients without the acquired immunodeficiency syndrome. Ann Intern Med. 1988 Nov 1;109(9):755–756. doi: 10.7326/0003-4819-109-9-755. [DOI] [PubMed] [Google Scholar]
  30. Olsson M., Elvin K., Löfdahl S., Linder E. Detection of Pneumocystis carinii DNA in sputum and bronchoalveolar lavage samples by polymerase chain reaction. J Clin Microbiol. 1993 Feb;31(2):221–226. doi: 10.1128/jcm.31.2.221-226.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Peglow S. L., Smulian A. G., Linke M. J., Pogue C. L., Nurre S., Crisler J., Phair J., Gold J. W., Armstrong D., Walzer P. D. Serologic responses to Pneumocystis carinii antigens in health and disease. J Infect Dis. 1990 Feb;161(2):296–306. doi: 10.1093/infdis/161.2.296. [DOI] [PubMed] [Google Scholar]
  32. Peters S. E., Wakefield A. E., Sinclair K., Millard P. R., Hopkin J. M. A search for Pneumocystis carinii in post-mortem lungs by DNA amplification. J Pathol. 1992 Feb;166(2):195–198. doi: 10.1002/path.1711660217. [DOI] [PubMed] [Google Scholar]
  33. Pifer L. L., Hughes W. T., Stagno S., Woods D. Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children. Pediatrics. 1978 Jan;61(1):35–41. [PubMed] [Google Scholar]
  34. Roux P., Lavrard I., Poirot J. L., Chouaid C., Denis M., Olivier J. L., Nigou M., Miltgen M. Usefulness of PCR for detection of Pneumocystis carinii DNA. J Clin Microbiol. 1994 Sep;32(9):2324–2326. doi: 10.1128/jcm.32.9.2324-2326.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. SHELDON W. H. Subclinical pneumocystis pneumonitis. AMA J Dis Child. 1959 Mar;97(3):287–297. doi: 10.1001/archpedi.1959.02070010289005. [DOI] [PubMed] [Google Scholar]
  36. Saah A. J., Hoover D. R., Peng Y., Phair J. P., Visscher B., Kingsley L. A., Schrager L. K. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study. JAMA. 1995 Apr 19;273(15):1197–1202. [PubMed] [Google Scholar]
  37. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29;239(4839):487–491. doi: 10.1126/science.2448875. [DOI] [PubMed] [Google Scholar]
  38. Santiago-Delpín E. A., Mora E., González Z. A., Morales-Otero L. A., Bermudez R. Factors in an outbreak of Pneumocystis carinii in a transplant unit. Transplant Proc. 1988 Feb;20(1 Suppl 1):462–465. [PubMed] [Google Scholar]
  39. Singer C., Armstrong D., Rosen P. P., Schottenfeld D. Pneumocystis carinii pneumonia: a cluster of eleven cases. Ann Intern Med. 1975 Jun;82(6):772–777. doi: 10.7326/0003-4819-82-6-722. [DOI] [PubMed] [Google Scholar]
  40. Stiller R. A., Paradis I. L., Dauber J. H. Subclinical pneumonitis due to Pneumocystis carinii in a young adult with elevated antibody titers to Epstein-Barr virus. J Infect Dis. 1992 Oct;166(4):926–930. doi: 10.1093/infdis/166.4.926. [DOI] [PubMed] [Google Scholar]
  41. Tamburrini E., Mencarini P., De Luca A., Maiuro G., Ventura G., Antinori A., Ammassari A., Visconti E., Ortona L., Siracusano A. Diagnosis of Pneumocystis carinii pneumonia: specificity and sensitivity of polymerase chain reaction in comparison with immunofluorescence in bronchoalveolar lavage specimens. J Med Microbiol. 1993 Jun;38(6):449–453. doi: 10.1099/00222615-38-6-449. [DOI] [PubMed] [Google Scholar]
  42. Wakefield A. E., Guiver L., Miller R. F., Hopkin J. M. DNA amplification on induced sputum samples for diagnosis of Pneumocystis carinii pneumonia. Lancet. 1991 Jun 8;337(8754):1378–1379. doi: 10.1016/0140-6736(91)93062-e. [DOI] [PubMed] [Google Scholar]
  43. Wakefield A. E., Miller R. F., Guiver L. A., Hopkin J. M. Granulomatous Pneumocystis carinii pneumonia: DNA amplification studies on bronchoscopic alveolar lavage samples. J Clin Pathol. 1994 Jul;47(7):664–666. doi: 10.1136/jcp.47.7.664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Wakefield A. E., Pixley F. J., Banerji S., Sinclair K., Miller R. F., Moxon E. R., Hopkin J. M. Amplification of mitochondrial ribosomal RNA sequences from Pneumocystis carinii DNA of rat and human origin. Mol Biochem Parasitol. 1990 Nov;43(1):69–76. doi: 10.1016/0166-6851(90)90131-5. [DOI] [PubMed] [Google Scholar]
  45. Walzer P. D., Perl D. P., Krogstad D. J., Rawson P. G., Schultz M. G. Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features. Ann Intern Med. 1974 Jan;80(1):83–93. doi: 10.7326/0003-4819-80-1-83. [DOI] [PubMed] [Google Scholar]
  46. Yale S. H., Limper A. H. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc. 1996 Jan;71(1):5–13. doi: 10.4065/71.1.5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES